CAS No.: 1959593-63-5
Yimitasvir diphosphate Catalog No. CSN51111
Synonyms: Emitasvir diphosphate;DAG-181 diphosphate
Emitasvir phosphate, a small-molecule inhibitor of HCV non-structural protein 5A (NS5A) developed by HEC Pharm, was approved in China in 2020 for the treatment of liver cirrhosis-free genotype 1 hepatitis C patients. The product is in phase III clinical development for the treatment of patients suffering from chronic genotype 1 hepatitis C, in a combination regimen with furaprevir and ribavirin.
| 规格 | 价格 | 促销价格 | 库存 | 数量 |
|---|
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 1959593-63-5 | 储存条件 |
|
|
| 分子式 | C49H64N8O14P2 | 运输 | 蓝冰 | |
| 分子量 | 1051.03 | 别名 | Emitasvir diphosphate;DAG-181 diphosphate |
